Lipid mediators in the pathophysiology of critical illness

被引:87
作者
Bulger, EM [1 ]
Maier, RV [1 ]
机构
[1] Univ Washington, Harborview Med Ctr, Dept Surg, Seattle, WA 98104 USA
关键词
lipid mediators; eicosanoids; prostaglandins; leukotrienes; thromboxane; platelet activating factor; omega-3 fatty acids; cyclooxygenase; lipoxygenase; systemic inflammatory response syndrome; acute respiratory distress syndrome; multiple organ failure syndrome; inflammation;
D O I
10.1097/00003246-200004001-00004
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Inflammatory lipid mediators are produced by the metabolism of membrane phospholipids following a number of different stimuli. These mediators lead to a variety of cellular and systemic responses which contribute to the manifestations of the systemic inflammatory response syndrome in the critically ill patient. These mediators include platelet-activating factor and the eicosanoids, including prostaglandins, thromboxanes, leukotrienes, and HETEs. This review seeks to evaluate the current role of these mediators in the pathophysiology of critical illness. We will focus on recent studies concerning the modulation of these pathways as a potential therapeutic strategy for management of these critically ill patients. This includes the gamut from nutritional strategies to alter the cellular membrane lipid composition, thereby effecting the substrate available to produce these lipid byproducts, to intracellular inhibitors to alter production of these mediators, to receptor blockage and enhanced clearance to inhibit their effects.
引用
收藏
页码:N27 / N36
页数:10
相关论文
共 129 条
[1]   Liposomal prostaglandin E(1) in acute respiratory distress syndrome: A placebo-controlled, randomized, double-blind, multicenter clinical trial [J].
Abraham, E ;
Park, YC ;
Covington, P ;
Conrad, SA ;
Schwartz, M .
CRITICAL CARE MEDICINE, 1996, 24 (01) :10-15
[2]  
ABRAMSON SB, 1991, J IMMUNOL, V147, P231
[3]  
AHMED T, 1986, AM REV RESPIR DIS, V134, P1149
[4]   Immunonutrition:: The role of ω-3 fatty acids [J].
Alexander, JW .
NUTRITION, 1998, 14 (7-8) :627-633
[5]   PHOSPHOLIPASE A(2) REGULATES CRITICAL INFLAMMATORY MEDIATORS OF MULTIPLE ORGAN FAILURE [J].
ANDERSON, BO ;
MOORE, EE ;
BANERJEE, A .
JOURNAL OF SURGICAL RESEARCH, 1994, 56 (02) :199-205
[6]  
ARBABI S, 1999, UNPUB J CLIN INVEST
[7]   Effects of ibuprofen on the physiology and survival of hypothermic sepsis [J].
Arons, MM ;
Wheeler, AP ;
Bernard, GR ;
Christman, BW ;
Russell, JA ;
Schein, R ;
Summer, WR ;
Steinberg, KP ;
Fulkerson, W ;
Wright, P ;
Dupont, WD ;
Swindell, BB .
CRITICAL CARE MEDICINE, 1999, 27 (04) :699-707
[8]   A prospective, randomized, double-blind, controlled clinical trial of enteral immunonutrition in the critically ill [J].
Atkinson, S ;
Sieffert, E ;
Bihari, D .
CRITICAL CARE MEDICINE, 1998, 26 (07) :1164-1172
[9]   RECEPTOR-MEDIATED ACTIVATION OF PHOSPHOLIPASE-A2 VIA GTP-BINDING PROTEINS - ARACHIDONIC-ACID AND ITS METABOLITES AS 2ND MESSENGERS [J].
AXELROD, J ;
BURCH, RM ;
JELSEMA, CL .
TRENDS IN NEUROSCIENCES, 1988, 11 (03) :117-123
[10]  
BALL HA, 1986, INTENS CARE MED, V12, P116